Skip to content

icometrix

Active
Public limited companyfounded 201115 yrs activeKolonel Begaultlaan 1B, 3012 Leuven, BelgiumKBO/BCE: BE 0833.377.379
Summary

The annual accounts of icometrix for fiscal year 2024 show a net loss of 82% of the equity at the start of that year. The 2024 annual accounts show equity of €3.27M and a net result of €-2.31M. Equity is shrinking by ~26.6% per year across the filed fiscal years. Its solvency ranks better than 51% of 226 sector peers (fiscal year 2024). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2024
59 / 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. A net loss of at least half of total assets or of the equity at the start of the financial year caps the score. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability0=
Solvency71=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €190k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 2.15 against 2.87 in 2023; short-term debt: 40.6% and cash: 44% of total assets), but 53.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 15 years 0 20 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
46.4%
Return on assets
-32.9%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-06-2025, 35 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
35 d early
2023
34 d early
2022
on the day
2021
22 d early
2020
25 d early
2019
31 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€3.27M▲ 15.4%
2023 · €2.83M
2018: €1.16M 2019: €15.95M 2020: €12.04M 2021: €8.84M 2022: €5.65M 2023: €2.83M
2018 → 2024
Total assets
€7.04M▲ 13.8%
2023 · €6.19M
2018: €2.86M 2019: €17.13M 2020: €15.04M 2021: €10.89M 2022: €7.72M 2023: €6.19M
2018 → 2024
Net result
€-2.31M▲ 17.8%
2023 · €-2.81M
2018: €-166k 2019: €-1.78M 2020: €-3.91M 2021: €-3.20M 2022: €-3.19M 2023: €-2.81M
2018 → 2024
Working capital
€3.29M▼ 2.6%
2023 · €3.38M
2018: €640k 2019: €15.44M 2020: €13.39M 2021: €8.92M 2022: €5.51M 2023: €3.38M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€12.04M-€8.84M▼ 26.6%€5.65M▼ 36.1%€2.83M▼ 49.9%€3.27M▲ 15.4%
Operating result€-3.88M-€-3.22M▲ 17.0%€-3.23M▼ 0.4%€-2.77M▲ 14.4%€-2.41M▲ 13.1%
Net result€-3.91M-€-3.20M▲ 18.2%€-3.19M▲ 0.3%€-2.81M▲ 11.8%€-2.31M▲ 17.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-4.00M€-3.00M€-2.00M€-1.00M€0Operating result 2020: €-3.88M€-3.88MNet result 2020: €-3.91M€-3.91MOperating result 2021: €-3.22M€-3.22MNet result 2021: €-3.20M€-3.20MOperating result 2022: €-3.23M€-3.23MNet result 2022: €-3.19M€-3.19MOperating result 2023: €-2.77M€-2.77MNet result 2023: €-2.81M€-2.81MOperating result 2024: €-2.41M€-2.41MNet result 2024: €-2.31M€-2.31M20202021202220232024€-4M€-3M€-2M€-1M€0Operating result 2022: €-3.23M€-3.2MNet result 2022: €-3.19M€-3.2MOperating result 2023: €-2.77M€-2.8MNet result 2023: €-2.81M€-2.8MOperating result 2024: €-2.41M€-2.4MNet result 2024: €-2.31M€-2.3M202220232024
The operating result stays negative: a loss of €2.41M in 2024 against €2.77M in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €7.04M
Fixed assets €893k ▼ 10.8%
Current assets €6.15M ▲ 18.5%
Equity and liabilities €7.04M
Equity €3.27M ▲ 15.4%
Debt €3.78M ▲ 12.4%
Debt's share of the balance-sheet total falls from 54.3% to 53.6%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€-1.96M
2023 · €-2.32M
Cash flow
€-1.87M
2023 · €-2.36M
Current ratio
2.15
2023 · 2.87
Debt to equity
1.16
2023 · 1.19
ROE
-70.9%
2023 · -99.4%
ROA
-32.9%
2023 · -45.5%
Interest coverage
-27.61
2023 · -22.05
Debt ≤ 1 year
€2.86M
2023 · €1.81M
Income taxes
€-12k
2023 · €-29k
Staff costs
€2.85M
2023 · €3.29M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 55 lines
Balance sheet Code20232024
Assets
Total assets20/58€6.19M€7.04M
Fixed assets21/28€1.00M€893k
Intangible fixed assets21€947k€862k
Tangible fixed assets22/27€55k€31k
Plant, machinery and equipment23€698€126
Furniture and vehicles24€13k€6k
Other tangible fixed assets26€40k€24k
Financial fixed assets28€95€95=
Current assets29/58€5.19M€6.15M
Amounts receivable after more than one year29€70k€73k
Other amounts receivable291€70k€73k
Amounts receivable within one year40/41€1.94M€2.37M
Trade receivables40€1.61M€1.93M
Other amounts receivable41€332k€443k
Cash at bank and in hand54/58€2.67M€3.10M
Deferred charges and accrued income490/1€504k€610k
Equity and liabilities
Total equity and liabilities10/49€6.19M€7.04M
Equity10/15€2.83M€3.27M
Contributions10/11€19.01M€5.56M
Capital10€4.22M€5.56M
Issued capital100€4.22M€5.56M
Outside capital11€14.79M€0
Share premium1100/10€14.79M€0
Reserves13€20k€20k=
Non-distributable reserves130/1€1k€1k=
Legal reserve130€1k€1k=
Distributable reserves133€19k€19k=
Profit (loss) carried forward14€-16.20M€-2.31M
Amounts payable17/49€3.36M€3.78M
Amounts payable within one year42/48€1.81M€2.86M
Trade debts44€360k€252k
Suppliers440/4€360k€252k
Advances received on contracts in progress46€1.11M€2.31M
Taxes, remuneration and social security45€334k€295k
Taxes450/3-€16k
Remuneration and social security454/9€334k€279k
Other amounts payable47/48€1k€1k=
Accrued charges and deferred income492/3€1.55M€920k
Income statement Code20232024
Remuneration, social security and pensions62€3.29M€2.85M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€453k€443k
Other operating charges640/8€19k€6k
Gross operating margin9900€993k€897k
Operating profit (loss)9901€-2.77M€-2.41M
Financial income75/76B€31k€150k
Recurring financial income75€31k€150k
Financial charges65/66B€105k€71k
Recurring financial charges65€105k€71k
Profit (loss) for the period before taxes9903€-2.84M€-2.33M
Income taxes67/77€-29k€-12k
Profit (loss) for the period9904€-2.81M€-2.31M
Profit (loss) for the period to be appropriated9905€-2.81M€-2.31M
Appropriation of the result
Profit (loss) to be appropriated9906€-16.20M€-18.52M
Profit (loss) brought forward from the previous period14P€-13.39M€-16.20M
Transfer from equity791/2-€16.20M
Social balance
Average headcount (FTE)908736.930.6

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
02-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital decrease · Capital6 facts ▸
  • General meeting, 24-06-2026
  • Capital increase, €3.000.000
  • Capital decrease, €8.774.561,41
  • Capital, €121.556,81
  • Statutes amendment
  • Premium booking, 700.000,00 EUR, Uitgiftepremies
09-01
State Gazette act Resignations: Vijay Barathan, Jonas Jeandupeux and 5 others
Appointments: 1D Sheep Collective BV, Kristof Callebaut and Stijn Cosyns · Mandate compensation · Power of attorney25 facts ▸
  • General meeting, 07-11-2025
  • Board meeting, 07-11-2025
  • Director resignation, Vijay Barathan (director)
  • Director resignation, Jonas Jeandupeux (director)
  • Director resignation, Twenty8Insight BV (director)
  • Director resignation, André Oosterlinck (director)
  • Director resignation, Capricorn Partners NV (director)
  • Director resignation, 1D Sheep Collective BV (director)
  • Director resignation, Heran Partners BV (director)
  • Director appointment, 1D Sheep Collective BV (director)
  • Director appointment, Kristof Callebaut (director)
  • Director appointment, Stijn Cosyns (director)
  • +13 further facts in this act
2025
08-12
State Gazette act Permanent representative: Wim Van Hecke
Statutes amendment · Shareholders agreement termination · Capital9 facts ▸
  • General meeting, 07-11-2025
  • Statutes amendment
  • Statutes amendment
  • Shareholders agreement termination, Beëindiging van de amended and restated aandeelhoudersovereenkomst de dato 13 september 2024 (waaronder onder andere een wijziging van de bepalingen met betrekk…
  • Capital, €5.896.118,22
  • Board composition, 1D Sheep Collective BV (director)
  • Permanent representative, Wim Van Hecke
  • Board composition, Kristof Callebaut (director)
  • Board composition, Stijn Cosyns (director)
26-11
State Gazette act Miscellaneous
Share cancellation · Capital · Power of attorney11 facts ▸
  • General meeting, 06-11-2025
  • Share cancellation, 130, 80 Inbreng in Natura, 50 Inbreng in Speciën
  • Share cancellation, 100, Soort D Anti-Dilutie Inschrijvingsrechten
  • Share cancellation, 20, verval
  • Share cancellation, 180, verval
  • Share cancellation, 712, niet uitoefenbaar omwille van het niet behalen van de voorwaarden voor 100% definitieve verwerving (vesting)
  • Share cancellation, 5706, niet-toegekend
  • Share cancellation, 19967, niet-toegekend
  • Capital
  • Share cancellation, 130, 03-05-2019
  • Power of attorney, Bestuursorgaan van icometrix
21-11
State Gazette act Appointments: twenty8insights BV (chair of the board) and André Oosterlinck (vice voorzitter van de raad van bestuur)
Resignation: Jay Miller (independent director) · Reappointments: Vijay Barathan (director) and Ernst en Young Bedrijfsrevisoren BV (statutory auditor) · Permanent representatives: Jan De Witte, Wim Van Hecke and 3 others28 facts ▸
  • Board meeting, 26-05-2025
  • General meeting, 13-06-2025
  • Share issue, soort A aandelen, 38522
  • Capital increase, €334.841,86
  • Bank account, KBC Bank NV
  • Capital, €5.896.118,22
  • Director appointment, twenty8insights BV (chair of the board)
  • Director appointment, André Oosterlinck (vice voorzitter van de raad van bestuur)
  • Director resignation, Jay Miller (independent director)
  • Director discharge, Jay Miller
  • Director appointment, twenty8insights BV (independent director)
  • Director reappointment, Vijay Barathan (director)
  • +16 further facts in this act
26-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
11-02
State Gazette act Miscellaneous
Share issue · Capital increase · Power of attorney6 facts ▸
  • General meeting, 27-01-2025
  • Share issue, Globaal Inschrijvingsrechtenplan 2025, 19967
  • Capital increase
  • Power of attorney, bestuursorgaan
  • Preemptive rights waiver, Afstand van het voorkeurrecht
  • Power of attorney, bestuursorgaan
2024
13-12
State Gazette act Permanent representatives: Herman Verrelst and Raf Roelands
3 facts ▸
  • Board meeting, 06-09-2024
  • Permanent representative, Herman Verrelst
  • Permanent representative, Raf Roelands
20-09
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Share cancellation20 facts ▸
  • General meeting, 13-09-2024
  • Capital increase, €263.471,4
  • Bank account, bijzondere rekening op naam van de Vennootschap bij KBC Bank NV
  • Share cancellation, ESOP-warrants, 2242
  • Share cancellation, SOP-warrants, 36850
  • Share issue, Soort C Anti-Dilutie Inschrijvingsrechten, 130
  • Share issue, Soort D Anti-Dilutie Inschrijvingsrechten, 100
  • Share issue, Globaal Inschrijvingsrechtenplan 2024, ESOP Inschrijvingsrechten
  • Share issue, Investeerder Inschrijvingsrechten, 20
  • Power of attorney, icometrix
  • Capital increase, €17.274.703,72
  • Capital decrease, €16.200.456,82
  • +8 further facts in this act
27-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
14-05
State Gazette act Resignation: Marieke Christmann (director)
Appointment: Jonas Jeandupeux (director)3 facts ▸
  • Board meeting, 28-03-2024
  • Director resignation, Marieke Christmann (director)
  • Director appointment, Jonas Jeandupeux (director)
2023
31-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
Show earlier events
31-03
State Gazette act Resignation: BDO Bedrijfsrevisoren BV (statutory auditor)
Appointment: Ernst en Young Bedrijfsrevisoren BV (statutory auditor) · Permanent representative: Brecht Deketele · Director discharge5 facts ▸
  • General meeting, 16-03-2023
  • Director resignation, BDO Bedrijfsrevisoren BV (statutory auditor)
  • Director discharge, BDO Bedrijfsrevisoren BV (statutory auditor)
  • Auditor appointment, Ernst en Young Bedrijfsrevisoren BV (statutory auditor)
  • Permanent representative, Brecht Deketele
2022
08-08
State Gazette act Appointments: Marieke Christmann, Vijay Barathan and André Oosterlinck
Resignation: Warner Consulting LLC (independent director) · Permanent representative: Amelia Warner7 facts ▸
  • General meeting, 10-06-2022
  • Director appointment, Marieke Christmann (forestay bestuurder)
  • Director appointment, Vijay Barathan (optum bestuurder)
  • Board meeting, 28-06-2022
  • Director resignation, Warner Consulting LLC (independent director)
  • Director appointment, André Oosterlinck (chair of the board)
  • Permanent representative, Amelia Warner
09-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
24-05
State Gazette act Resignations: Stephan (Steve) Rietiker, Ndiawar Sar and Heather Roxborough
Reappointments: 1D Sheep Collective, Capricorn Partners and 2 others · Permanent representatives: Wim Van Hecke, Katrin Geyskens and Amelia Warner · Appointments: Ndiawar Sar, Warner Consulting, LLC. and 2 others21 facts ▸
  • General meeting, 26-10-2020
  • Director resignation, Stephan (Steve) Rietiker (independent director)
  • General meeting, 11-06-2021
  • Director reappointment, 1D Sheep Collective (a bestuurder)
  • Permanent representative, Wim Van Hecke
  • Director reappointment, Capricorn Partners (b bestuurder)
  • Permanent representative, Katrin Geyskens
  • Director reappointment, Jay Miller (director)
  • Auditor reappointment, BDO Bedrijfsrevisoren BV
  • Director appointment, Ndiawar Sar (forestay bestuurder)
  • Director appointment, Ndiawar Sar (forestay bestuurder)
  • Director appointment, Warner Consulting, LLC. (independent director)
  • +9 further facts in this act
2021
06-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
23-03
State Gazette act Resignation: Frédéric Wohlwend (director)
Appointment: Sar Ndiawar Seydou (director) · Power of attorney4 facts ▸
  • Board meeting, 29-01-2021
  • Director resignation, Frédéric Wohlwend (director)
  • Director appointment, Sar Ndiawar Seydou (director)
  • Power of attorney, Four and Five Law BV
2020
31-12
Financial Weakest financial yearnet €-3.91M
Net result drops to €-3.91M, the lowest in the series; recovery starts the following year.
31-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 31 days late
10-08
State Gazette act Resignation: HERAN (director)
Appointment: HERAN PARTNERS (director) · Permanent representative: Herman Verrelst5 facts ▸
  • General meeting, 13-07-2020
  • Director resignation, HERAN (director)
  • Director appointment, HERAN PARTNERS (director)
  • Permanent representative, Herman Verrelst
  • Permanent representative, Herman Verrelst
05-06
State Gazette act Resignations: Jomale (a bestuurder) and OOSTERLINCK André (independent director)
Appointments: OOSTERLINCK André (a bestuurder) and RIETIKER Steve (independent director) · Permanent representatives: VAN HECKE Wim, OOSTERLINCK André and 2 others · Statutes amendment23 facts ▸
  • General meeting, 25-05-2020
  • Statutes amendment
  • Capital, €4.223.558,06
  • Director resignation, Jomale (a bestuurder)
  • Director resignation, OOSTERLINCK André (independent director)
  • Director appointment, OOSTERLINCK André (a bestuurder)
  • Director appointment, RIETIKER Steve (independent director)
  • Mandate compensation, OOSTERLINCK André
  • Mandate compensation, RIETIKER Steve
  • Board composition, WOHLWEND Frédéric (forestay bestuurder)
  • Board composition, ROXBOROUGH Heather (optum bestuurder)
  • Board composition, 1D Sheep Collective (a bestuurder)
  • +11 further facts in this act
30-04
State Gazette act Resignation: PARIZEL Paul (director)
Appointments: WOHLWEND Frédéric Charles-Edouard (forestay bestuurder) and ROXBOROUGH Heather Elaine (optum bestuurder) · Permanent representatives: LOECKX Dirk, VAN HECKE Wim and 2 others · Registered-office move31 facts ▸
  • General meeting, 03-05-2019
  • Registered-office move, 3012 Leuven, Kolonel Begaultlaan 1B bus 12
  • Capital, €2.641.821,96
  • Capital increase, €195.415
  • Capital increase, €88.324,24
  • Capital increase, €1.493.411,86
  • Capital, €4.223.558,06
  • Share issue, Anti-Dilutie Warrants, 130
  • Share issue, Indemnification Warrants, 180
  • Share issue, SOP-Warrants, 48002
  • Share cancellation, SOP-Warrants, 14258
  • Director resignation, PARIZEL Paul (director)
  • +19 further facts in this act
2019
31-12
Financial Liquidity times 15current ratio 23.38
Current ratio from 1.60 to 23.38; short-term debt falls from €1.07M to €690k.
31-12
Financial Equity above €10MEq €15.95M ▲1272%
Equity rises from €1.16M to €15.95M.
21-11
State Gazette act Appointment: 1D Sheep Collective BVBA (day-to-day manager)
Permanent representative: Wim Van Hecke3 facts ▸
  • Board meeting, 04-09-2019
  • Director appointment, 1D Sheep Collective BVBA (day-to-day manager)
  • Permanent representative, Wim Van Hecke
04-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
27-05
State Gazette act Reappointment: BDO Bedrijfsrevisoren (statutory auditor)
Appointment: Jay Miller (ab bestuurder)3 facts ▸
  • General meeting, 11-05-2018
  • Auditor reappointment, BDO Bedrijfsrevisoren (statutory auditor)
  • Director appointment, Jay Miller (ab bestuurder)
16-05
State Gazette act Resignation: PARIZEL Paul (director)
Appointments: WOHLWEND Frédéric Charles-Edouard (forestay bestuurder) and ROXBOROUGH Heather Elaine (optum bestuurder) · Permanent representatives: LOECKX Dirk, VAN HECKE Wim and 2 others · Registered-office move31 facts ▸
  • General meeting, 03-05-2019
  • Registered-office move, 3012 Leuven, Kolonel Begaultlaan 1B bus 12
  • Capital increase, €88.324,24
  • Capital increase, €1.493.411,86
  • Bank account, BE37 7350 5300 4828
  • Share issue, Anti-Dilutie Warrants, 130
  • Share issue, Indemnification Warrants, 180
  • Share cancellation, SOP-Warrants, 14258
  • Share issue, SOP-Warrants, 48002
  • Statutes amendment
  • Statutes amendment
  • Capital, €4.223.558,06
  • +19 further facts in this act
12-04
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 05-02-2019
2018
18-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
02-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
22-06
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
27-01
State Gazette act Resignation: icoMetrix (voltallige raad van bestuur)
Appointments: Jomale BVBA, 1D Sheep Collective BVBA and 5 others · Permanent representatives: Dirk Loeckx, Wim Van Hecke and 2 others · Share cancellation34 facts ▸
  • General meeting, 29-12-2015
  • Share cancellation, winstbewijzen klasse C, 35640
  • Share issue, Omzetting van 49.800 winstbewijzen (A1, A2, A3, B1, B2) in aandelen van dezelfde klassen
  • Statutes amendment
  • Capital increase, €44.290,35
  • Capital increase, €91.578,24
  • Bank account, BE30 7390 1227 1511
  • Capital increase, €1.990.546,09
  • Capital increase, €106.264,41
  • Capital, €2.446.406,96
  • Name change, icometrix
  • Statutes amendment
  • +22 further facts in this act
2015
08-09
State Gazette act Resignations: Dirk Loeckx (director) and Wim Van Hecke (director)
Appointments: Jomale BVBA (director) and The 1D sheep collective BVBA (director) · Permanent representatives: Dirk Loeckx and Wim Van Hecke · Mandate compensation10 facts ▸
  • General meeting, 08-05-2015
  • Director resignation, Dirk Loeckx (director)
  • Director resignation, Dirk Loeckx (managing director)
  • Director resignation, Wim Van Hecke (director)
  • Director appointment, Jomale BVBA (director)
  • Director appointment, The 1D sheep collective BVBA (director)
  • Permanent representative, Dirk Loeckx
  • Permanent representative, Wim Van Hecke
  • Mandate compensation, Jomale BVBA
  • Mandate compensation, The 1D sheep collective BVBA
2013
16-09
State Gazette act Reappointments: Dirk Loeckx, Wim Van Hecke and 3 others
Appointments: Herman Verrelst, Paul Parizel and Dirk Loeckx9 facts ▸
  • General meeting, 10-05-2013
  • Director reappointment, Dirk Loeckx (director)
  • Director reappointment, Wim Van Hecke (director)
  • Director appointment, Herman Verrelst (director)
  • Director appointment, Paul Parizel (director)
  • Director reappointment, André Oosterlinck (director)
  • Director reappointment, Jean-Pierre Timmermans (director)
  • Director reappointment, Jean-Pierre Pradier (director)
  • Director appointment, Dirk Loeckx (managing director)
2012
14-12
State Gazette act Resignation: Stefan Sunaert (director)
2 facts ▸
  • Board meeting, 17-10-2012
  • Director resignation, Stefan Sunaert (director)
03-05
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 16-04-2012
  • Registered-office move, Tervuursesteenweg 244, Leuven/Heverlee
2011
12-07
State Gazette act Reappointments: Loeckx Dirk, Van Hecke Wim and Sunaert Stefan
Appointments: Pradier Jean-Pierre, Oosterlinck André Jules Joseph and Timmermans Jean Pierre Paul · Capital increase · Bank account15 facts ▸
  • General meeting, 15-06-2011
  • Capital increase, €18.358,89
  • Bank account, Bank J. Van Breda & C°
  • Capital increase, €131.797,77
  • Share issue, winstbewijzen met stemrecht, 35640
  • Statutes amendment
  • Capital, €213.727,87
  • Director reappointment, Loeckx Dirk (director)
  • Director reappointment, Van Hecke Wim (director)
  • Director reappointment, Sunaert Stefan (director)
  • Director appointment, Pradier Jean-Pierre (director)
  • Director appointment, Oosterlinck André Jules Joseph (director)
  • +3 further facts in this act
14-02
State Gazette act Incorporation
Appointments: Loeckx Dirk, Van Hecke Wim Raph Gaby and Sunaert Stefan Georges Philippe · Founding capital · Bank account11 facts ▸
  • Incorporation, 20-01-2011
  • Founding capital, €63.571,21
  • Bank account, Bank van Breda
  • Director appointment, Loeckx Dirk (director)
  • Director appointment, Van Hecke Wim Raph Gaby (director)
  • Director appointment, Sunaert Stefan Georges Philippe (director)
  • Mandate compensation, Loeckx Dirk
  • Board meeting, 20-01-2011
  • Director appointment, Van Hecke Wim Raph Gaby (chair of the board)
  • Director appointment, Loeckx Dirk (managing director)
  • Profit certificate issuance, 49800, dezelfde rechten als de kapitaalaandelen met stemrecht voor wat betreft de winstverdeling, alsook voor wat betreft het aandeel in het vereffeningsoversch…
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
21 directors, no change since 2025
1D Sheep Collective BV
Director · since 07-11-2025 · Legal entity
Current
Kristof Callebaut
Director · since 07-11-2025
Current
Stijn Cosyns
Director · since 07-11-2025
Current
twenty8insight
Independent director · since 26-05-2025 · Private limited company · perm. rep.: Jan De Witte
Current
CAPRICORN PARTNERS
B bestuurder · since 11-06-2021 · Public limited company · perm. rep.: Katrin Geyskens
Current
Sar Ndiawar Seydou
Director · since 29-01-2021
Current
15 other directors
1D Sheep Collective
A bestuurder · since 03-06-2015 · Private limited company · perm. rep.: Wim Van Hecke
Current
Heran Partners
Director · since 27-05-2020 · Private limited company · perm. rep.: Herman Verrelst
Not recently confirmed
RIETIKER Steve
Independent director · since 25-05-2020
Not recently confirmed
ROXBOROUGH Heather Elaine
Optum bestuurder · since 03-05-2019
Not recently confirmed
WOHLWEND Frédéric Charles-Edouard
Forestay bestuurder · since 03-05-2019
Not recently confirmed
1D Sheep Collective BVBA
Day-to-day manager · since 04-09-2019 · Legal entity · perm. rep.: Wim Van Hecke
Not recently confirmed
Capricorn Venture Partners NV
B bestuurder · since 29-12-2015 · Legal entity · perm. rep.: Geyskens
Not recently confirmed
HERAN BVBA
B bestuurder · since 29-12-2015 · Legal entity · perm. rep.: Herman Verrelst
Not recently confirmed
Jomale
A bestuurder · since 03-06-2015 · Private limited company · perm. rep.: Dirk Loeckx
Not recently confirmed
Herman Verrelst
Director · since 10-05-2013
Not recently confirmed
Jean-Pierre Pradier
Director · since 15-06-2011
Not recently confirmed
Not recently confirmed
Timmermans Jean Pierre Paul
Director · since 15-06-2011
Not recently confirmed
Stefan Georges Philippe Sunaert
Director · since 20-01-2011
Not recently confirmed
Wim Raph Gaby Van Hecke
Director · since 20-01-2011
Not recently confirmed
07-11-2025 1D Sheep Collective BV: Reappointed as Director
07-11-2025 1D Sheep Collective BV: Resigned as Day-to-day manager
07-11-2025 Kristof Callebaut: Appointed as Director
07-11-2025 Kristof Callebaut: Appointed as Day-to-day manager
07-11-2025 Kristof Callebaut: Appointed as Chair
Full history in the Timeline (69 changes) →
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2011
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Kolonel Begaultlaan 1B3012 Leuven
Ground area
8,983 m²
Building footprint
4,164 m²
Volume, LiDAR
63,164 m³
Parcel 24126D0179/00D002, Flanders · tallest building 24.7 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
icometrix
Kolonel Begaultlaan 1B, 3012 LeuvenScientific research and development
since 20112.196.485.618
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24126D0179/00D002 Flanders 8,983 m² 1 · 4,164 m² 24.7 m · 5 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
Ernst et Young Reviseurs d'EntreprisesCurrent
Auditor · represented by Brecht Deketele
21-02-2023 → present
Show 3 earlier auditors
BDO Bedrijfsrevisoren
Statutory auditor
succeeded by BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES in 2020
29-12-2015 → 26-10-2020
BDO Bedrijfsrevisoren bv
Statutory auditor
- → 21-02-2023
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Auditor
succeeded by Ernst et Young Reviseurs d'Entreprises in 2023
26-10-2020 → 21-02-2023

Articles of association

Purpose
Het aanbieden van producten en diensten in biomedische, diagnostische en therapeutische domeinen, bijvoorbeeld door systemen en activiteiten te ontwikkelen, te verhandelen en te…
Full purpose

Het aanbieden van producten en diensten in biomedische, diagnostische en therapeutische domeinen, bijvoorbeeld door systemen en activiteiten te ontwikkelen, te verhandelen en te commercialiseren steunend op medische beeldbewerking.

Structure & network

Connections & network

24 connected companies
Alumni Lovanienses, Shared director ALAlumniLovaniensesASSOCIATIE KU Leuven, Shared director AKASSOCIATIE KULeuvenAssociatie Universiteit & Hogescholen Antwerpen, Shared director AUAssociatieUniversiteit…EASICS, Shared director EEASICSFONDATION CONTRE LE CANCER, Shared director FCFONDATION CONTRELE CANCERFONDS FEDERAL DE LA RECHERCHE SCIENTIFIQUE, Shared director FFFONDS FEDERALDE LA…Fonds voor wetenschappelijk Onderzoek - Vlaanderen, Shared director FVFonds voorwetenschappelijk…IMEC International, Shared director IIIMECInternationalInteruniversitair Micro-Electronica Centrum, Shared director IMInteruniversi…Micro-Electro…LUCA School of Arts, Shared director LSLUCA School ofArtsSCOUTS EN GIDSEN VLAANDEREN, Shared director SESCOUTS EN GIDSENVLAANDERENSEPTENTRIO, Shared director SSEPTENTRIOThe British School of Brussels, Shared director TBThe BritishSchool of…VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY, Shared director VIVLAAMSINSTITUUT…icometrix icometrix0833.377.379
Shared directors
Linked via shared directors
Alumni Lovanienses
Shared director
ASSOCIATIE KU Leuven
Shared director
EASICS
Shared director
Show 20 more companies with a shared director
IMEC International
Shared director
LUCA School of Arts
Shared director
SEPTENTRIO
Shared director
ARKITE
Shared corporate director
CAPRICORN ICT ARKIV
Shared corporate director
ENDO TOOLS THERAPEUTICS
Shared corporate director
FEops
Shared corporate director
Lynxcare Clinical Informatics
Shared corporate director
PUNCH POWERTRAIN
Shared corporate director
Sensolus
Shared corporate director
Spectricity
Shared corporate director
UgenTec
Shared corporate director

Capital and shareholders

Shareholders according to the acts
After 2 capital increases act of 12-07-2011 ↗
  • Katholieke Universiteit Leuven 11,713 shares · 59,192.44 EUR
  • Universiteit Antwerpen 10,200 shares · 51,546.39 EUR
  • Universitair Ziekenhuis Antwerpen 1,800 shares · 9,096.42 EUR
  • Koning Boudewijnstichting 6,000 shares · 30,321.41 EUR

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 02-07-2026 Capital increase of 3,000,000 EUR · to 8,896,118.22 EUR · in cash
  2. 02-07-2026 Capital reduction of 8,774,561.41 EUR · to 121,556.81 EUR · “aanzuivering van geleden verliezen”
  3. 08-12-2025 Capital stated in the act · 5,896,118.22 EUR · 678,321 shares
  4. 26-11-2025 Capital stated in the act · 678,321 shares
  5. 21-11-2025 Capital increase of 334,841.86 EUR · to 5,896,118.22 EUR
  6. 20-09-2024 Capital increase of 263,471.40 EUR · to 4,487,029.46 EUR · 37,569 new shares
  7. 20-09-2024 Capital increase of 17,274,703.72 EUR · to 21,761,733.18 EUR
  8. 20-09-2024 Capital reduction of 16,200,456.82 EUR · to 5,561,276.36 EUR · “aanzuivering van geleden verliezen”
Show 13 older capital entries
  1. 05-06-2020 Capital stated in the act · 4,223,558.06 EUR · 602,230 shares
  2. 30-04-2020 Capital increase of 195,415 EUR · to 2,641,821.96 EUR · 78,166 new shares
  3. 30-04-2020 Capital increase of 88,324.24 EUR · to 2,730,146.20 EUR · 12,594 new shares
  4. 30-04-2020 Capital increase of 1,493,411.86 EUR · to 4,223,558.06 EUR · 212,943 new shares
  5. 16-05-2019 Capital increase of 88,324.24 EUR · to 2,730,146.20 EUR · 12,594 new shares
  6. 16-05-2019 Capital increase of 1,493,411.86 EUR · to 4,223,558.06 EUR · 212,943 new shares
  7. 27-01-2016 Capital increase of 44,290.35 EUR · to 258,018.22 EUR · 37,855 new shares · in kind
  8. 27-01-2016 Capital increase of 91,578.24 EUR · to 349,596.46 EUR · 78,272 new shares · in cash
  9. 27-01-2016 Capital increase of 1,990,546.09 EUR · to 2,340,142.55 EUR · no new shares · from reserves
  10. 27-01-2016 Capital increase of 106,264.41 EUR · to 2,446,406.96 EUR · no new shares · in cash
  11. 12-07-2011 Capital increase of 18,358.89 EUR · to 81,930.10 EUR · 29,713 new shares
  12. 12-07-2011 Capital increase of 131,797.77 EUR · to 213,727.87 EUR · from reserves
  13. 14-02-2011 Incorporation · 63,571.21 EUR · 102,887 shares

Public money · subsidies and aid

Flemish government

2022 to 2025 · 7 entries · 293,627 EUR awarded · 130,064 EUR paid
Year Entries awardedpaid
2025 3 274,091 EUR110,528 EUR
2024 1 1,491 EUR1,491 EUR
2023 1 12,000 EUR12,000 EUR
2022 2 6,045 EUR6,045 EUR
Schemes
Strategisch onderzoekscentrum ICON project (SOC-ICON)
1 entry · 271,563 EUR · 108,000 EUR paid · Fonds voor Innoveren en Ondernemen
Vlaams opleidingsverlof (VOV)
4 entries · 19,615 EUR · 19,615 EUR paid · Departement Werk en Sociale Economie
Subsidies voor internationaal ondernemen
1 entry · 1,250 EUR · 1,250 EUR paid · Vlaams Agentschap voor Internationaal Ondernemen
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 1,199 EUR · 1,199 EUR paid · Fonds voor Innoveren en Ondernemen

European Union, budget

2024 to 2025 · 3 entries · 1,128,238 EUR in total
Year Entries awarded
2025 2 865,620 EUR
2024 1 262,618 EUR
Projects
BRAIN DISEASE MONITORING THROUGH THE LIFE SPAN POWERED BY ARTIFICIAL INTELLIGENCE
Horizon Europe · 01-11-2025 to 31-10-2029 · 865,620 EUR · BRIDGE-AI
IQ-BRAIN - IMPROVING QMRI BY REALIZING TRUSTWORTHY INTEGRATION OF AI IN NEURO-IMAGING
Horizon Europe · 01-12-2024 to 30-11-2028 · 262,618 EUR

European research

17 projects · 1 as coordinator · 9,436,485 EUR EU contribution
Programmes
Horizon 2020
8 entries · 3,784,558 EUR
Horizon Europe
6 entries · 3,116,240 EUR
Seventh Framework Programme
3 entries · 2,535,688 EUR
Projects
Collaborative European NeuroTrauma Effectiveness Research in TBI
Seventh Framework Programme · participant · 01-10-2013 to 31-03-2020 · 2,110,000 EUR · CENTER-TBI
CLinical impact through AI-assisted MS care
Horizon Europe · participant · 01-06-2023 to 31-05-2027 · 974,500 EUR · CLAIMS
BRaIn Disease monitoring throuGh the lifE span powered by Artificial Intelligence
Horizon Europe · participant · 01-11-2025 to 31-10-2029 · 865,620 EUR · BRIDGE-AI
AI-based chest CT analysis enabling rapid COVID diagnosis and prognosis
Horizon 2020 · coordinator · 01-09-2020 to 28-02-2023 · 849,993 EUR · icovid
PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM
Horizon Europe · participant · 01-11-2023 to 31-10-2027 · 698,500 EUR · PREDICTOM
Show 12 more projects
Data-driven models for Progression Of Neurological Disease
Horizon 2020 · participant · 01-01-2016 to 31-12-2020 · 638,625 EUR · EuroPOND
NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION
Horizon 2020 · participant · 01-01-2018 to 30-06-2023 · 530,500 EUR · RESTORE
Breakthroughs in Quantitative Magnetic resonance ImagiNg for improved DEtection of brain Diseases
Horizon 2020 · participant · 01-01-2018 to 31-03-2022 · 501,120 EUR · B-Q MINDED
Translational Brain Imaging Training Network
Horizon 2020 · participant · 01-10-2017 to 30-09-2022 · 501,120 EUR · TRABIT
Multi AI-Agents to Revolutionise the Management of Neurological Diseases
Horizon Europe · participant · 01-05-2026 to 30-04-2030 · 315,000 EUR · CEREBRIS
Improving QMRI By Realizing trustworthy integration of AI in Neuro-imaging
Horizon Europe · participant · 01-12-2024 to 30-11-2028 · 262,620 EUR · IQ-BRAIN
INtegrating Magnetic Resonance SPectroscopy and Multimodal Imaging for Research and Education in MEDicine
Horizon 2020 · participant · 01-01-2019 to 30-06-2023 · 256,320 EUR · INSPiRE-MED
PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis
Horizon 2020 · participant · 01-11-2020 to 30-04-2025 · 256,320 EUR · PARENT
Advancing brain research in children’s developmental neurocognitive disorders
Horizon 2020 · participant · 01-03-2015 to 28-02-2019 · 250,560 EUR · ChildBrain
Transforming Magnetic Resonance Spectroscopy into a Clinical Tool
Seventh Framework Programme · participant · 01-03-2013 to 28-02-2017 · 238,040 EUR · TRANSACT
Molecular Imaging of Brain Pathophysiology
Seventh Framework Programme · participant · 01-10-2013 to 30-09-2017 · 187,648 EUR · BrainPath
Novel brain health solutions across four focus areas: Prevention and care, Methods and data, Innovation and society, and Ethics and well-being
Horizon Europe · associated partner · 01-12-2024 to 30-11-2029 · NOVEL

Similar companies · same sector, comparable size

Of 1,177 companies in sector 72109 we hold annual accounts for 715. 346 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded20-01-2011
Fiscal year end31-12
Activities, NACEBEL 2025
72109Other research and development on natural sciences
62900Other information technology and computer services
62200Computer consultancy and computer facilities management
63100Computing infrastructure, data processing, hosting and related activities
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

Contact details

3 entries
Enterprise
E-mail:info@icometrix.com
Enterprise
Phone:+3216369000
Enterprise